Maldives vs North Macedonia: Access to anti-retroviral drugs, male
Maldives
60.0%
in 2024
North Macedonia
60.0%
in 2024
Maldives rank
102nd
North Macedonia rank
102nd
Access to anti-retroviral drugs, male over time
- Maldives
- North Macedonia
How they compare
Maldives currently reports 60.0% against 60.0% in North Macedonia, a difference of 0.0%.
The two have swapped places 6 times across 25 shared years of data; in 2000 it was North Macedonia ahead.
Maldives ranks 102nd and North Macedonia ranks 102nd of 141 countries.
Across the 3 decades both report, Maldives averaged higher in 2 and North Macedonia in 1.
Head to head by decade
| Decade | Maldives | North Macedonia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 29.4% | 9.6% | 19.8% | Maldives |
| 2010s | 34.2% | 33.3% | 0.9% | Maldives |
| 2020s | 54.2% | 55.8% | 1.6% | North Macedonia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Maldives or North Macedonia?
- Maldives, at 60.0% against 60.0% in North Macedonia as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Maldives and North Macedonia?
- 0.0%, with Maldives ahead.
- How many years of comparable data are there for Maldives and North Macedonia?
- 25 years are reported by both, from 2000 to 2024.
- How do Maldives and North Macedonia rank globally for access to anti-retroviral drugs, male?
- Maldives ranks 102nd and North Macedonia ranks 102nd of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.